newsfilter
← Latest News
Business Wire·

Lost Money in Sesen Bio, Inc.?

Gibbs Law Group Investigates Potential Securities Law Violations Sesen Bio, Inc. shares plummeted after a STAT News report claimed the FDA's recent rejection of the company's clinical trial for its drug Vicineum was due to "thousands of violations of